Literature DB >> 25995995

The regulation of the p53/MDM2 feedback loop by microRNAs.

Cen Zhang1, Juan Liu1, Xiaolong Wang1, Zhaohui Feng1.   

Abstract

Tumor suppressor p53 and its signaling pathway play a central role in tumor prevention. The E3 ubiquitin ligase MDM2, which is a direct p53 transcriptional target and also the most critical negative regulator of p53, forms an autoregulatory negative feedback loop with p53 in the cell to tightly regulate the levels and activity of p53. MicroRNAs (miRNAs) are endogenously expressed small non-coding RNAs that play a critical role in the post-translational regulation of gene expression. Recent studies have revealed that miRNAs directly regulate the levels of p53 or MDM2 to modulate the p53 function in tumor suppression. Recently, we identified miR-339-5p as a new miRNA that directly represses MDM2 to activate p53 and enhance p53 function in tumor suppression. Thus, miRNAs have become a new but important component of the p53 signaling pathway through regulating the p53/MDM2 feedback loop.

Entities:  

Keywords:  MDM2; microRNA; p53; tumor

Year:  2015        PMID: 25995995      PMCID: PMC4435570          DOI: 10.14800/rd.502

Source DB:  PubMed          Journal:  RNA Dis        ISSN: 2375-2467


  28 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

Review 2.  Blinded by the Light: The Growing Complexity of p53.

Authors:  Karen H Vousden; Carol Prives
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

Review 3.  MicroRNAs in the p53 network: micromanagement of tumour suppression.

Authors:  Heiko Hermeking
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

4.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

5.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

Review 6.  Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Authors:  Mark Wade; Geoffrey M Wahl
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

Review 7.  The P53 pathway: what questions remain to be explored?

Authors:  A J Levine; W Hu; Z Feng
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

Review 8.  The MDM2 gene amplification database.

Authors:  J Momand; D Jung; S Wilczynski; J Niland
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

Review 9.  MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  EMBO Mol Med       Date:  2012-02-20       Impact factor: 12.137

10.  miR-339-5p inhibits cell migration and invasion in vitro and may be associated with the tumor-node-metastasis staging and lymph node metastasis of non-small cell lung cancer.

Authors:  Yun Li; Weiguo Zhao; Pengtao Bao; Chunsun Li; Xiu Qing Ma; Yanqing Li; Liang An Chen
Journal:  Oncol Lett       Date:  2014-05-22       Impact factor: 2.967

View more
  8 in total

1.  microRNA-29 mediates a novel negative feedback loop to regulate SCAP/SREBP-1 and lipid metabolism.

Authors:  Peng Ru; Deliang Guo
Journal:  RNA Dis       Date:  2017-03-20

2.  Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.

Authors:  Rafaela Muniz de Queiroz; Rashna Madan; Jeremy Chien; Wagner Barbosa Dias; Chad Slawson
Journal:  J Biol Chem       Date:  2016-07-11       Impact factor: 5.157

Review 3.  The Complex Interaction between P53 and miRNAs Joins New Awareness in Physiological Stress Responses.

Authors:  Camilla Capaccia; Silvana Diverio; Danilo Zampini; Gabriella Guelfi
Journal:  Cells       Date:  2022-05-13       Impact factor: 7.666

Review 4.  Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma.

Authors:  Ana B Herrero; Elizabeta A Rojas; Irena Misiewicz-Krzeminska; Patryk Krzeminski; Norma C Gutiérrez
Journal:  Int J Mol Sci       Date:  2016-11-30       Impact factor: 5.923

5.  MicroRNA expression patterns and target prediction in multiple myeloma development and malignancy.

Authors:  Ivyna Pau Ni Bong; Ching Ching Ng; Puteri Baharuddin; Zubaidah Zakaria
Journal:  Genes Genomics       Date:  2017-02-09       Impact factor: 1.839

Review 6.  Anticancer Activity and Underlying Mechanism of Phytochemicals against Multiple Myeloma.

Authors:  Beomku Kang; Hyunmin Park; Bonglee Kim
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

Review 7.  Non-Coding RNA: Sequence-Specific Guide for Chromatin Modification and DNA Damage Signaling.

Authors:  Sofia Francia
Journal:  Front Genet       Date:  2015-11-13       Impact factor: 4.599

8.  miR-29a sensitizes the response of glioma cells to temozolomide by modulating the P53/MDM2 feedback loop.

Authors:  Qiudan Chen; Weifeng Wang; Shuying Chen; Xiaotong Chen; Yong Lin
Journal:  Cell Mol Biol Lett       Date:  2021-05-27       Impact factor: 5.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.